medigraphic.com
SPANISH

Archivos en Medicina Familiar

Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 6

<< Back Next >>

Arch Med Fam 2024; 26 (6)

Staphylococcus aureus Eczema: a case Report and Review of the Literature

Tavera VMA, Ruíz MLY
Full text How to cite this article

Language: Spanish
References: 10
Page: 315-317
PDF size: 187.53 Kb.


Key words:

Staphylococcus aureus, eczema, treatment.

ABSTRACT

Staphylococcus aureus is a pathogen that causes tissue infections of variable severity, with high resistance to antibiotic use. We present the clinical case of a patient with type 2 diabetes and systemic arterial hypertension who presented eczema caused by Staphylococcus aureus with initial treatment failure, who underwent culture with antibiogram to guide therapeutic management, showing clinical improvement. This ailment recurrently affects susceptible patients; therefore, we must have clinical suspicion and provide a comprehensive approach as primary care physicians.


REFERENCES

  1. Moret Serralta A. Dermatología en Atención Primaria.Editorial Médica Panamericana; 2017.

  2. Fitzpatrick TB, Goldsmith LA. Dermatología en medicinageneral. 8a ed. Buenos Aires: Médica Panamericana;2013.

  3. Arenas Guzmán R. Dermatología. Ciudad de México:McGraw-Hill Interamericana; 2019.

  4. Kuraitis D, Williams L. Decolonization of Staphylococcusaureus in Healthcare: A Dermatology Perspective.J Healthc Eng. 2018;201(8):1-8.

  5. Bjerre RD, Bandier J, Skov L, Engstrand L, Johansen JD.The role of the skin microbiome in atopic dermatitis: asystematic review. Br J Dermatol. 2017;177(5):1272-8.

  6. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, AkiyamaH, Kaplan DH, et al. Dysbiosis and Staphylococcus aureusColonization Drives Inflammation in Atopic Dermatitis.Immunity. 2015;42(4):756-66.

  7. Geoghegan JA, Irvine AD, Foster TJ. Staphylococcusaureus and Atopic Dermatitis: A Complex and EvolvingRelationship. Trends Microbiol. 2018;26(6):484-97.

  8. Neuber K, König W, Ring J. [Staphylococcus aureus andatopic eczema]. Hautarzt Z Dermatol Venerol VerwandteGeb. 1993;44(3):135-42.

  9. Banerjee N. How effective are interventions to reduceStaphylococcus aureus in eczema? Clin Exp Allergy.2022;52(2):219-21.

  10. Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-RemyC, Sotto A, Lavigne JP, et al. Staphylococcus aureusToxins: An Update on Their Pathogenic Properties andPotential Treatments. Toxins. 2021;13(10):677.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Fam. 2024;26